Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations

Volumn 34, Issue 10, 2016, Pages 432.e1-432.e8

  Vallo, Stefan ^a   Gilfrich, Christian ^b   Burger, Maximilian ^c   Volkmer, Björn ^d   Boehm, Katharina ^e   Rink, Michael ^e   Chun, Felix K ^e   Roghmann, Florian ^f   Novotny, Vladimir ^g   Mani, Jens ^a   Brisuda, Antonin ^h   Mayr, Roman ^c,i   Stredele, Regina ^d   Noldus, Joachim ^f   Schnabel, Marco ^c   May, Matthias ^b   Fritsche, Hans Martin ^c   Pycha, Armin ⁱ   Martini, Thomas ^i,j   Wirth, Manfred ^g   Roigas, Jan ^k   Bastian, Patrick J ^l   Nuhn, Philipp ^j   Dahlem, Roland ^e   Haferkamp, Axel ^a   Fisch, Margit ^e   Aziz, Atiqullah ^e   more..

^a GOETHE UNIVERSITY   (Germany)

^b Department of Urology   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d Department of Pathology   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

ⁱ CENTRAL HOSPITAL OF BOLZANO   (Italy)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^l MARIEN HOSPITAL DÜSSELDORF   (Germany)

more..

Author keywords

Bladder cancer; Mortality; Outcome; Prostatic invasion pattern; Radical cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER WALL; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INFILTRATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CARCINOMA IN SITU; COMPARATIVE STUDY; CYSTECTOMY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE URETHRA; PROSTATIC INVASION; RISK ASSESSMENT; SOFT TISSUE; TUMOR INVASION; UROTHELIAL CARCINOMA OF BLADDER; ADJUVANT CHEMOTHERAPY; BLADDER; BLADDER TUMOR; BLOOD VESSEL; LYMPH VESSEL; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATE; RISK FACTOR; SECONDARY; SMOOTH MUSCLE; SURGICAL MARGIN; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

AGED; BLOOD VESSELS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MARGINS OF EXCISION; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; RISK FACTORS; SURVIVAL RATE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84991080767     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2016.05.008     Document Type: Article

References (31)

1. [1] Stenzl, A., Cowan, N.C., De Santis, M., et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59 (2011), 1009–1018.
2. [2] Donat, S.M., Genega, E.M., Herr, H.W., et al. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 165 (2001), 1117–1120.
3. [3] Revelo, M., Cookson, M., Chang, S., et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171 (2004), 646–651.
4. [4] May, M., Bastian, P.J., Brookman-May, S., et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31 (2013), 1141–1147.
5. [5] Aziz, A., Shariat, S.F., Roghmann, F., et al. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making., 117, 2016, 272–279.
6. [6] Cheville, J.C., Dundore, P.A., Bostwick, D.G., et al. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer 82 (1998), 703–707.
7. [7] Njinou-Ngninkeu, B., Lorge, F., Moulin, P., et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 169 (2003), 149–152.
8. [8] Shen, S.S., Lerner, S.P., Muezzinoglu, B., et al. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 37 (2006), 726–734.
9. [9] Greene, F.L., Page, D.L., Flemming, I.D., American Joint Committee on Cancer Staging Manual, 6th ed, 2009, Springer-Verlag, New York.
10. [10] Witjes, J.A., Compérat, E., Cowan, N.C., et al. EAU Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65 (2014), 778–792.
11. [11] Lotan, Y., Gupta, A., Shariat, S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005), 6533–6539.
12. [12] Rink, M., Fajkovic, H., Cha, E.K., et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61 (2012), 854–855.
13. [13] Satagopan, J.M., Ben-Porat, L., Berwick, M., et al. A note on competing risks in survival data analysis. Br J Cancer 91 (2004), 1229–1235.
14. [14] Heagerty, P.J., Lumley, T., Pepe, M.S., Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56 (2000), 337–344.
15. [15] Vickers, A.J., Elkin, E.B., Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26 (2006), 565–574.
16. [16] Tilki, D., Svatek, R.S., Karakiewicz, P.I., et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183 (2010), 1757–1763.
17. [17] May, M., Aziz, A., Brookman-May, S., et al. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series. World J Urol 33 (2015), 343–350.
18. [18] May, M., Brookman-May, S., Burger, M., et al. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy. Ann Surg Oncol 21 (2014), 4034–4040.
19. [19] Ichihara, K., Masumori, N., Kitamura, H., et al. Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens. Int J Clin Oncol 19 (2014), 152–156.
20. [20] Barocas, D.A., Patel, S.G., Chang, S.S., et al. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology. BJU Int 104 (2009), 1091–1097.
21. [21] Knoedler, J.J., Boorjian, S.A., Tollefson, M.K., et al. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy. BJU Int 114 (2014), 832–836.
22. [22] Patel, A.R., Cohn, J.A., Abd El Latif, A., et al. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol 189 (2013), 53–58.
23. [23] Esrig, D., Freeman, J.A., Elmajian, D.A., et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 156 (1996), 1071–1076.
24. [24] Liberman, D., Alasker, A., Sun, M., et al. Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 107 (2011), 905–911.
25. [25] Novotny, V., Froehner, M., May, M., et al. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. World J Urol 33 (2015), 1753–1761.
26. [26] Novara, G., Svatek, R.S., Karakiewicz, P.I., et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 183 (2010), 2165–2170.
27. [27] Xylinas, E., Rink, M., Novara, G., et al. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol 20 (2013), 1027–1034.
28. [28] Kaushik, D., Frank, I., Eisenberg, M.S., et al. Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol 32 (2014), 1433–1439.
29. [29] Petrelli, F., Coinu, A., Cabiddu, M., et al. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis. Eur Urol 65 (2014), 350–357.
30. [30] Burger, M., Mulders, P., Witjes, W., Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61 (2012), 1070–1071.
31. [31] Gakis, G., Witjes, J.A., Compérat, E., et al. European Association of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol 64 (2013), 823–830.